Ebrima Bah

1.2k total citations
14 papers, 448 citations indexed

About

Ebrima Bah is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Ebrima Bah has authored 14 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Ebrima Bah's work include Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (4 papers). Ebrima Bah is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (4 papers). Ebrima Bah collaborates with scholars based in France, Gambia and United States. Ebrima Bah's co-authors include Pierre Hainaut, Maimuna Mendy, Andrew J. Hall, Hilton Whittle, Gregory D. Kirk, Olufunmilayo Lesi, Omar Sam, Marianne A. B. van der Sande, Aliu Akano and Christopher P. Wild and has published in prestigious journals such as PLoS ONE, Environmental Health Perspectives and International Journal of Cancer.

In The Last Decade

Ebrima Bah

12 papers receiving 433 citations

Peers

Ebrima Bah
Ebrima Bah
Citations per year, relative to Ebrima Bah Ebrima Bah (= 1×) peers Jen‐Eing Jeng

Countries citing papers authored by Ebrima Bah

Since Specialization
Citations

This map shows the geographic impact of Ebrima Bah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebrima Bah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebrima Bah more than expected).

Fields of papers citing papers by Ebrima Bah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebrima Bah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebrima Bah. The network helps show where Ebrima Bah may publish in the future.

Co-authorship network of co-authors of Ebrima Bah

This figure shows the co-authorship network connecting the top 25 collaborators of Ebrima Bah. A scholar is included among the top collaborators of Ebrima Bah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebrima Bah. Ebrima Bah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Njie, Ramou, Lamin Jaiteh, Ousman Nyan, et al.. (2024). Clinical Characteristics and Prognostic Factors of COVID‐19 Patients Admitted to the National Treatment Center in The Gambia. Advances in Public Health. 2024(1).
2.
Bah, Ebrima, et al.. (2013). 20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West Africa. PLoS ONE. 8(9). e75775–e75775. 14 indexed citations
3.
Sighoko, Dominique, Bakarou Kamaté, Cheick Bougadari Traoré, et al.. (2013). Breast cancer in pre-menopausal women in West Africa: Analysis of temporal trends and evaluation of risk factors associated with reproductive life. The Breast. 22(5). 828–835. 40 indexed citations
4.
Shimakawa, Yusuke, Ebrima Bah, Christopher P. Wild, & Andrew J. Hall. (2012). Evaluation of data quality at the Gambia national cancer registry. International Journal of Cancer. 132(3). 658–665. 32 indexed citations
5.
Gouas, Doriane, Stéphanie Villar, Sandra Ortiz‐Cuaran, et al.. (2012). TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis. 33(6). 1219–1224. 34 indexed citations
6.
Gouas, Doriane, Sandra Ortiz‐Cuaran, Pénélope Legros, et al.. (2012). Editorial_Board. Carcinogenesis. 33(6). NP–NP. 36 indexed citations
7.
Villar, Stéphanie, Doriane Gouas, Amelie Plymoth, et al.. (2011). Seasonal Variation in TP53 R249S -Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection. Environmental Health Perspectives. 119(11). 1635–1640. 29 indexed citations
8.
Sighoko, Dominique, et al.. (2011). Increase in Female Liver Cancer in The Gambia, West Africa: Evidence from 19 Years of Population-Based Cancer Registration (1988–2006). PLoS ONE. 6(4). e18415–e18415. 23 indexed citations
9.
Sighoko, Dominique, Ebrima Bah, Jari Haukka, et al.. (2010). Population‐based breast (female) and cervix cancer rates in the Gambia: Evidence of ethnicity‐related variations. International Journal of Cancer. 127(10). 2248–2256. 20 indexed citations
10.
Lesi, Olufunmilayo, Maimuna Mendy, Ebrima Bah, et al.. (2010). Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia. Liver International. 31(2). 215–221. 35 indexed citations
11.
Kuniholm, Mark H., Olufunmilayo Lesi, Maimuna Mendy, et al.. (2008). Aflatoxin Exposure and Viral Hepatitis in the Etiology of Liver Cirrhosis in The Gambia, West Africa. Environmental Health Perspectives. 116(11). 1553–1557. 59 indexed citations
12.
Viviani, Simonetta, Patrizia Carrieri, Ebrima Bah, et al.. (2008). 20 Years into the Gambia Hepatitis Intervention Study: Assessment of Initial Hypotheses and Prospects for Evaluation of Protective Effectiveness Against Liver Cancer. Cancer Epidemiology Biomarkers & Prevention. 17(11). 3216–3223. 56 indexed citations
13.
Sande, Marianne A. B. van der, Pauline A. Waight, Maimuna Mendy, et al.. (2007). Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence. PLoS ONE. 2(8). e753–e753. 70 indexed citations
14.
Bah, Ebrima & Pierre Hainaut. (2006). Liver cancer prevention in The Gambia, West Africa.. Cancer Epidemiology and Prevention Biomarkers. 15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026